Enveric Biosciences, Inc. 10-Q

ITEM 5. OTHER INFORMATION None ITEM 6. EXHIBITS 31.1* Section 302 Certification of Principal Executive Officer 31.2* Section 302 Certification of Principal Financial and Accounting Officer 32.1** Section 906 Certification of Principal Executive Officer 32.2** Section 906 Certification of Principal Financial and Accounting Officer 101** The following materials from Ameri Holdings, Inc.’s Quarterly Report on Form 10-Q for the three months ended September 30, 2019 are formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statement of Stockholders’ Equity (Deficit), (iv) the Consolidated Statements of Cash Flow, and (iv) Notes to the Consolidated Financial Statements. * Furnished herewith. ** In accordance with Item 601of Regulation S-K, this Exhibit is hereby furnished to the SEC as an accompanying document and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933. 30 Table of Contents SIGNATURES Pursuant to the requirements of the Section 13 or 15 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 16 day of November, 2020. AMERI Holdings, Inc. By: /s/ Brent Kelton Brent Kelton Chief Executive Officer (Principal Executive Officer) By: /s/ Barry Kostiner Barry Kostiner Chief Financial Officer (Principal Accounting Officer) 31